Lung Neoplasms: all 7,334 studies
Page 38 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1CompletedNCT04718012
- 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique PatientsCompletedNCT04717804Not applicable
- Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation TherapyActive, not recruitingNCT04716946Phase 2
- Pilot Digital Follow-up of Lung CancerCompletedNCT04712149Not applicable
- Endobronchial Cryotherapy in Management of MEBO in Patients With Inoperable NSCLCCompletedNCT04710459Not applicable
- DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic CriteriaStatus unknownNCT04708483Not applicable
- Pyrotinib Combined With Pemetrexed Plus Carboplatin in the First-line TreatmentStatus unknownNCT04706949Phase 2
- Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerTerminatedNCT04705025Not applicable
- CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapyStatus unknownNCT04704960
- LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04703153
- Image - Navigated Resection of Lung NodulesCompletedNCT04702165Phase 1/2
- Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine CarcinomasActive, not recruitingNCT04701307Phase 2
- Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationActive, not recruitingNCT04699188Phase 1/2
- Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st ChemotherapyStatus unknownNCT04698941Phase 2
- NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) TrialTerminatedNCT04698681
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer PatientsStatus unknownNCT04696939Phase 2
- Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).Status unknownNCT04690686Phase 2
- Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive MutationsActive, not recruitingNCT04687241Phase 3
- Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung CancerActive, not recruitingNCT04685070Phase 2
- Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLCStatus unknownNCT04683198Phase 2
- Gut Microbiota and Cancer Immunotherapy ResponseStatus unknownNCT04682327
- Lung Ultrasound to Assess Aeration Loss After Lung Resection SurgeryCompletedNCT04677309
- Key Performance Indicators for the Assessment of NSCLC Patients PathwayCompletedNCT04676321
- Feasibility of an Acute Physical Exercise Before Treatment Infusion for Metastatic Lung Cancer PatientsCompletedNCT04676009Not applicable
- Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung CancerStatus unknownNCT04675697Phase 2
- A Patient and Provider Intervention to Address Health Disparities in Lung Cancer ScreeningActive, not recruitingNCT04675476Not applicable
- Central Nervous System(CNS) Efficacy of DacomitinibStatus unknownNCT04675008Phase 2
- A Real-world Study of Durvalumab for Lung Cancer in ChinaStatus unknownNCT04672759
- A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLCCompletedNCT04672369Phase 1
- A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung CancerCompletedNCT04672356Phase 1
- To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung CancerCompletedNCT04671303Phase 2
- The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard TherapyStatus unknownNCT04667975Phase 1
- Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United KingdomCompletedNCT04667312
- Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung SurgeryCompletedNCT04665531Not applicable
- Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLCStatus unknownNCT04663438
- Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter SurvivalCompletedNCT04663191
- Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their CaregiversCompletedNCT04662645Not applicable
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）Status unknownNCT04659785Phase 1/2
- Lung Cancer RegistryCompletedNCT04654364
- Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent ChemoradiotherapyCompletedNCT04654234
- Immune Checkpoints in COPDStatus unknownNCT04654104
- SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung CancerWithdrawnNCT04650490Phase 2
- Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
- Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLCWithdrawnNCT04648189Phase 2
- A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung CancerStatus unknownNCT04647357Phase 2
- A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT04647344Phase 1/2
- Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics ModelsStatus unknownNCT04646837Phase 1/2
- Almonertinib With Chemotherapy in mEGFR NSCLCStatus unknownNCT04646824Phase 2
- A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain MetastasesStatus unknownNCT04643847Phase 2
- A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung CancerStatus unknownNCT04641754Phase 2
- Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.CompletedNCT04640935
- The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With AfatinibCompletedNCT04640870
- A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)CompletedNCT04636762Phase 2
- A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLCStatus unknownNCT04636593Phase 2
- Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer ScreeningCompletedNCT04635761Not applicable
- The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the LungCompletedNCT04634630
- Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer PatientsCompletedNCT04633850
- Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) PatientsActive, not recruitingNCT04632758Phase 3
- Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer PatientsStatus unknownNCT04632342Phase 2
- Supportive Care Mobile Application for Patients With NSCLCCompletedNCT04629300Not applicable
- Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care ImagingStatus unknownNCT04629079
- Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLCStatus unknownNCT04629027
- Early Detection of Lung Cancer in Czech High-risk Asymptomatic IndividualsStatus unknownNCT04627350
- Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant TreatmentWithdrawnNCT04625699Phase 2
- Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Active, not recruitingNCT04625647Phase 2
- XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT04622072Phase 1
- A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung CancerCompletedNCT04620330Phase 2
- "Impact of a Nursing Intervention in the Management of Oncological Patients With Lung Cancer Under Treatment With Immunotherapy"CompletedNCT04619810Not applicable
- A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer PatientsStatus unknownNCT04619563Phase 2
- A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung CancerStatus unknownNCT04619537Phase 2
- Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung TumorsCompletedNCT04619472Not applicable
- US NAB With ROSE Versus US FNAB With no ROSECompletedNCT04618874Not applicable
- Lung Cancer Risk and Early Detection in FirefightersCompletedNCT04614129Not applicable
- Using Connected Health to Increase Lung Cancer ScreeningCompletedNCT04612946Not applicable
- A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLCStatus unknownNCT04612673Phase 2
- Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLCTerminatedNCT04610658Phase 1
- Pilot Prehabilitation Intervention in Lung CancerTerminatedNCT04610606Not applicable
- Yoga Program for Improving the Quality of Life in Couples Coping With CancerActive, not recruitingNCT04607590Not applicable
- Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2Status unknownNCT04604470
- Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)Active, not recruitingNCT04602533Phase 2
- Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung CancerApproved for marketingNCT04599712
- TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyTerminatedNCT04596033Phase 1
- Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.Status unknownNCT04595734
- Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung CancerStatus unknownNCT04592666Phase 2
- Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLCStatus unknownNCT04586465Phase 2
- Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung VentilationCompletedNCT04583046Not applicable
- A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLCActive, not recruitingNCT04580498Phase 2
- Accelerated Radio-Immunotherapy for Lung CancerCompletedNCT04577638Phase 2
- A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788WithdrawnNCT04576208Phase 2
- Exercise, Nutrition, and Palliative Care in Advanced Lung Cancer (ENPAL)CompletedNCT04575831Not applicable
- The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor CellsStatus unknownNCT04568720
- Telerehabilitation in Lung Surgery PatientsCompletedNCT04568564Not applicable
- Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid BiopsiesCompletedNCT04566614
- Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC PatientsCompletedNCT04566432
- SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLCActive, not recruitingNCT04562337Phase 2
- A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line TreatmentStatus unknownNCT04560244Phase 2
- A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung CancerStatus unknownNCT04558255
- Breath Analysis in Early Stage Lung Cancer Using Infrared SpectroscopyTerminatedNCT04556435